A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors

被引：0

作者：

Le Saux, Olivia ^{[1
]}

Italiano, Antoine ^{[2
]}

Spaeth, Dominique ^{[3
]}

Heudel, Pierre ^{[4
]}

Filleron, Thomas ^{[5
]}

Albiges, Laurence ^{[6
]}

Bachelot, Thomas ^{[4
]}

Goncalves, Anthony ^{[7
]}

Pierga, Jean-Yves ^{[8
]}

Barlesi, Fabrice ^{[9
]}

Boige, Valerie ^{[6
]}

Lebbe, Celeste ^{[10
]}

Mortier, Laurent ^{[11
]}

Frenel, Jean Sebastien ^{[12
]}

Tredan, Olivier ^{[4
]}

Jimenez, Marta ^{[13
]}

Legrand, Francois ^{[13
]}

Ferte, Charles ^{[14
]}

机构：

[1] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France

[2] Inst Bergonie, Bordeaux, France

[3] Ctr Oncol Gentilly, Nancy, France

[4] Ctr Leon Berard, Lyon, France

[5] Inst Univ Canc Toulouse, Toulouse, France

[6] Gustave Roussy, Villejuif, France

[7] Ctr Paoli Calmette, Marseille, France

[8] Inst Curie, Paris, France

[9] AP HM, Marseille, France

[10] Hop St Louis, Paris, France

[11] CHU Lille, Lille, France

[12] ICO Ctr Rene Gauducheau, Nantes, France

[13] UNICANCER R&D, Paris, France

[14] MEDIMMUNE, Bethesda, MD USA

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-CT153

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT153

引用

页数：3

共 6 条

[1] EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors
Italiano, A.
Le Saux, O.
Andre, F.
Filleron, T.
Spaeth, D.
Heudel, P-E.
Albiges, L.
Bachelot, T.
Goncalves, A.
Pierga, J-Y.
Barlesi, F.
Boige, V.
Lebbe, C.
Mortier, L.
Frenel, J-S.
Tredan, O.
Jimenez, M.
Legrand, F.
Ferte, C.
ANNALS OF ONCOLOGY, 2018, 29 : 57 - 57
[2] EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors
Le Saux, O.
Italiano, A.
Spaeth, D.
Heudel, P-E.
Filleron, T.
Pezzella, V.
Jimenez, M.
Legrand, F.
Ferte, C.
ANNALS OF ONCOLOGY, 2018, 29
[3] Express study: A trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors.
Le Saux, Olivia
Italiano, Antoine
Andre, Fabrice
Filleron, Thomas
Spaeth, Dominique
Heudel, Pierre-Etienne
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[4] EXPRESS study: A trial exploring the association of low level of genomic alteration with exceptional and unexpected response to targeted therapies in patients with advanced solid tumors
Le Saux, Olivia
Girard, Elodie
Leslie, Lori
Bachelot, Thomas
Pierga, Jean-Yves
Barlesi, Fabrice
Albiges, Laurence
Lebbe, Celeste
Boige, Valerie
Frenel, Jean-Sebastien
Spaeth, Dominique
Guillot, Aline
Heudel, Pierre Etienne
Gardner, Miriam
Durando, Xavier
Peron, Julien
Kamal, Maud
Legrand, Francois
Lusque, Amelie
Bieche, Ivan
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[5] Association between serum levels of C-reactive protein and response to treatment of chemotherapy-induced anemia in patients with solid tumors: a multicenter, prospective, observational study
Esquerdo Galiana, Gaspar
Manuel Cervera, Jose
Barrajon, Enrique
Juarez, Asuncion
Llorca, Cristina
Diaz, Nieves
Lopez, Antonio
Peiro, Rafael
MEDICAL ONCOLOGY, 2013, 30 (01)
[6] Association between serum levels of C-reactive protein and response to treatment of chemotherapy-induced anemia in patients with solid tumors: a multicenter, prospective, observational study
Gaspar Esquerdo Galiana
Jose Manuel Cervera
Enrique Barrajón
Asunción Juárez
Cristina Llorca
Nieves Díaz
Antonio López
Rafael Peiró
Medical Oncology, 2013, 30

← 1 →